19 June 2013
Keywords: imclone, ucb, ink, deal, cdp-791, biotechnology, group
Article | 22 August 2005
US biotechnology group ImClone Systems and Belgian drugmaker UCB Pharma have entered into a worldwide strategic partnership for the development
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
22 August 2005
15 August 2005
18 June 2013
© 2013 thepharmaletter.com